Mindfulness group experiences for young people at high risk for or early in psychosis
Official title: Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study
Run by Centre Psychothérapique de Nancy · NCT07499934 · Data updated 2026-11-12
This project tries to understand how group mindfulness sessions feel for French-speaking young people aged 15–30 who are at ultra‑high risk for psychosis or have had a first episode.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 30 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Centre Psychothérapique de Nancy Academic / other |
| Locations | 2 sites (Laxou and 1 other locations) |
| Status | Recruiting |
| Started | January 19, 2026 |
| Main results expected | January 19, 2027 |
| Study ends | July 19, 2027 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT07499934 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are French-speaking individuals aged 15–30 who meet CAARMS criteria for UHR or first-episode psychosis with significant social functional impact (SOFAS <50 or >30% decline) and who can provide informed consent.
✕Probably not a fit
People with a prior episode of schizophrenia, schizoaffective disorder, or bipolar disorder, those with prolonged antipsychotic exposure, significant intellectual disability or organic mental disorders, non‑French speakers, or individuals unable to consent (including minors without parental authorization) are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Using a qualitative phenomenological approach, researchers will interview 15–30-year-olds who met CAARMS criteria for ultra‑high risk (UHR) or first-episode psychosis (FEP) and who participated in group-based mindfulness interventions. Interviews will focus on participants' lived experiences, perceived benefits, and any adverse effects linked to the mindfulness groups. Recruitment occurs at two French psychiatric centers, and participants must be able to give informed consent and speak French. Transcripts will be thematically analyzed to identify common patterns that could inform safer and more acceptable mindfulness offerings for this population.
Why it matters
Potential benefit: If successful, the findings could help clinicians design safer, more acceptable mindfulness programs that better support young people at high risk for psychosis.
How similar studies have gone: Previous studies indicate mindfulness can be feasible and helpful for some individuals on the psychosis spectrum, but qualitative exploration specifically in UHR/FEP groups is limited and adverse effects have been underreported.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * People aged between 15 and 30 years who meet the criteria for UHR or PEP status on the CAARMS scale and have a social functional impact (SOFAS score less than 50 or a decrease of more than 30% in the score) Exclusion Criteria: * \- Previous episode of schizophrenia, schizoaffective disorder, or bipolar disorder * Previous antipsychotic treatment for more than 12 months * Organic mental disorder or intellectual disability * Serious suicide/homicidal risk (but admissible if this risk has been resolved) * Insufficient French language skills * Adult unable to give consent and not under legal guardianship * Protective measure (guardianship/conservatorship/judicial protection) or under judicial supervision * Person deprived of liberty by judicial or administrative decision (including actual involuntary hospitalization) * Persons in a life-threatening emergency * Not affiliated with a social security scheme * Minors without parental authorization * Person who refused the audio recording of the interview
Where it's running
-
Centre Psychothérapique de Nancy
Laxou, France Recruiting -
Clinique Fondation Santé des Etudiants de France
Vitry-le-François, France Recruiting
Study contacts
- Principal investigator: william DALFIN — Centre Psychothérapique de Nancy
- Study coordinator: William DALFIN, MD
- Email: william.dalfin@cpn-laxou.com
- Phone: +33 3 83 92 68 22
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Accelerated Brain Stimulation for Young People at Risk of Psychosis
This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Biomarker changes after MT1988 dosing in young people at high risk for psychosis
This will test whether two doses of MT1988 taken twice daily for 8 weeks change biomarker tests in 17–30-year-olds at high risk for psychosis compared with placebo.
-
Digital DBT for Youth at Risk of Psychosis
This study tests a self-guided digital DBT program to help young people aged 14–35 who are at clinical high risk for psychosis, comparing it to usual care over eight weeks.
-
French version of the Schizophrenia Proneness Instrument for children and adolescents (SPI-CY)
This project will test the French SPI-CY to see if it reliably identifies French-speaking adolescents (ages 12–17) who are at high risk for developing psychosis.
-
Cognitive training and enhanced treatment for youth at high risk of psychosis in Tunisia
This study is testing two different treatment approaches to see if they can help young people at high risk for psychosis improve their daily functioning over 12 weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.